Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Operating Expenses (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Operating Expenses for 16 consecutive years, with $27.4 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 6.3% to $27.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $110.6 million through Dec 2025, up 12.15% year-over-year, with the annual reading at $110.6 million for FY2025, 12.15% up from the prior year.
  • Operating Expenses for Q4 2025 was $27.4 million at Lemaitre Vascular, up from $25.6 million in the prior quarter.
  • The five-year high for Operating Expenses was $28.8 million in Q2 2025, with the low at $15.7 million in Q2 2021.
  • Average Operating Expenses over 5 years is $22.1 million, with a median of $22.8 million recorded in 2023.
  • The sharpest move saw Operating Expenses decreased 1.71% in 2021, then soared 40.7% in 2022.
  • Over 5 years, Operating Expenses stood at $17.7 million in 2021, then increased by 8.11% to $19.1 million in 2022, then rose by 20.81% to $23.1 million in 2023, then rose by 11.61% to $25.7 million in 2024, then rose by 6.3% to $27.4 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $27.4 million, $25.6 million, and $28.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.